PIM
VYGR icon

Partner Investment Management’s Voyager Therapeutics VYGR Stock Holding History

Partner Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,378
Closed -$196K – 67
2019
Q3 		$196K Sell
11,378
-66
-0.6% -$1.39K 0.34% 54
2019
Q2 		$312K Buy
11,444
+1,308
+13% +$29.9K 0.33% 62
2019
Q1 		$194K Buy
+10,136
New +$132K 0.22% 74
2017
Q4 		– Sell
-4,844
Closed -$100K – 96
2017
Q3 		$100K Sell
4,844
-11,573
-70% -$131K 0.09% 82
2017
Q2 		$147K Sell
16,417
-17,726
-52% -$178K 0.2% 79
2017
Q1 		$452K Sell
34,143
-113
-0.3% -$1.37K 0.55% 64
2016
Q4 		$436K Sell
34,256
-128,022
-79% -$1.64M 0.58% 58
2016
Q3 		$1.95M Buy
162,278
+136,091
+520% +$1.84M 2.89% 6
2016
Q2 		$288K Buy
26,187
+11,852
+83% +$145K 0.47% 62
2016
Q1 		$120K Sell
14,335
-49
-0.3% -$556 0.2% 75
2015
Q4 		$285K Buy
+14,384
New +$331K 0.47% 53

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Partner Investment Management's VYGR Position: Q4 2019 in Review

Partner Investment Management sold out of Voyager Therapeutics (VYGR) in Q4 2019, closing a stake of 11,378 shares — an estimated $196K sold.

Partner Investment Management first reported a position in VYGR in Q4 2015 and held it in 11 quarters. The position peaked at $1.95M in Q3 2016. 138 funds tracked by Wall St. Rank hold VYGR as of Q4 2019.

  • Partner Investment Management reported no remaining Voyager Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Partner Investment Management sold 11,378 Voyager Therapeutics shares in Q4 2019, an estimated $196K.
  • Partner Investment Management first reported a position in Voyager Therapeutics in Q4 2015 and held it in 11 quarters.
  • Partner Investment Management's Voyager Therapeutics position peaked at $1.95M in Q3 2016.
  • 138 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2019.

Based on Partner Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.